Earthquake, Tsunami Disrupt Pharma Manufacturing in Japan
This article was originally published in The Gold Sheet
Executive Summary
TOKYO - Following a massive earthquake, tsunami, and potential nuclear disaster, Japan's leading pharmaceutical companies like Astellas Pharma Inc. are joining the rest of the country in assessing and responding to the damage.